Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$3.36 - $7.99 $3.53 Million - $8.4 Million
-1,050,938 Reduced 46.7%
1,199,625 $9.59 Million
Q3 2022

Nov 14, 2022

SELL
$0.51 - $4.84 $382,212 - $3.63 Million
-749,437 Reduced 24.98%
2,250,563 $7.25 Million
Q4 2021

Feb 14, 2022

BUY
$5.86 - $13.52 $17.6 Million - $40.6 Million
3,000,000 New
3,000,000 $30.2 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.49B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Palantir Technologies Inc. Portfolio

Follow Palantir Technologies Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palantir Technologies Inc., based on Form 13F filings with the SEC.

News

Stay updated on Palantir Technologies Inc. with notifications on news.